---
$id: https://graph.org.ai/products/commodity/51131646
$type: Product
source: UNSPSC
code: "51131646"
title: "Napsagatran"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Napsagatran

**UNSPSC Code**: 51131646
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VL5IZU8PF8. European Medicines Agency schedules Napsagatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09161MIG. Napsagatran generally arises in the molecular formula C26H34N6O6S.H2O. The term NAPSAGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35.) NAPSAGATRAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule napsagatran under HS 29350090 and SITC 51580. As of Q4 2014, NAPSAGATRAN remains the US FDA Preferred Term for this commodity. Napsagatran bears US NLM identifiers UMLS ID C0380191 and NCI Concept Code C90703. SMILES: S(=O)(=O)(NC(C(=O)N(C1CC1)CC(=O)O)CC(=O)NCC1CCCN(C1)C(=N)N)C1CC2C(CC1)CCCC2.

